Trial Profile

A Clinical study of ONCO-Boost as treatment for osteosarcoma

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 08 Feb 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs ONCO Boost HEPHAISTOS Pharma (Primary)
Indications Osteosarcoma
Focus Adverse reactions

Most Recent Events

08 Feb 2024 New trial record
23 Jan 2024 According to a HEPHAISTOS-Pharma media release, HEPHAISTOS-Pharma announced that it has raised a 2 million euro seed round to finance GMP transfer and ONCO-Boost towards the clinic. The round was co-led by xista science ventures and the Foundation Fournier-Majoie, with the participation of Noshaq

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com